Th1/Th2 response profiles to the major allergens Cry j 1 and Cry j 2 of Japanese cedar pollen

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 10, 1996, Pages 732-740

  Sugimura, K ^a   Hashiguchi, S ^a   Takahashi, Y ^a   Hino, K ^b   Taniguchi, Y ^b   Kurimoto, M ^b   Fukuda, K ^a   Ohyama, M ^a   Yamada, G ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Allergen; Cry j 1; Cry j 2; Japanese cedar pollen; Pollinosis

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; POLLEN ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; LYMPHOCYTE PROLIFERATION; POLLEN ALLERGY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029851841     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04455.x     Document Type: Article

References (42)

1. Mosmann TR, Coffman RL. Two types of mouse helper T-cell clone; implication for immune regulation. Immunol Today 1987;8:223-7.
2. O'Hehir RE, Hoyne GF, Thomas WR, Lamb JR. House dust mite allergy: from T-cell epitopes to immunotherapy. J Clin Invest 1993;23:763-72.
3. Thomas WR, Chua KY. Molecular analysis of house dust mite allergens. Prog Immunol 1992;8:427-33.
4. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci U S A 1995;92:3611-15.
5. Skeiky YAW, Guderian JA, Benson DR, et al. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med 1995; 181:1527-37.
6. Hashiguchi S, Hino K, Taniguchi Y, et al. Immunodominance of seven regions of a major allergen. Cry j 2, of Japanese cedar pollen for T-cell immunity. Allergy 1996;51:621-32
7. Ohtsuki T, Taniguchi Y, Kohno K, Fukuda S, Usui M, Kurimoto M. Cry j 2, a major allergen of Japanese cedar pollen, shows polymethylgalacturonase activity. Allergy 1995;50:483-8.
8. Sakaguchi M, Inouye S, Taniai M, Andou S, Usui M, Matuhasi T. Identification of the second major allergen of Japanese cedar pollen. Allergy 1990;45:309-12.
9. Taniai M, Ando S, Usui M, et al. N-terminal amino acid sequence of a major allergen of Japanese cedar pollen (Cry j I). FEBS Lett 1988;239:329-32.
10. Taniai M, Kayano T, Takakura R, et al. Epitopes on Cry j I and Cry j II for the human IgE antibodies cross-reactive between Cupressus sempervirens and Cryptomeria japonica pollen. Mol Immunol 1993;30:183-9.
11. Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983;71:77-86.
12. Takahashi Y, Mizoguchi J, Katagiri S. Development and distribution of the major pollen allergen (Cry j 1) in male flower buds of Japanese cedar (Cryptomeria japonica) [in Japanese with English summary]. Jpn J Allergol 1989; 38:1354-8.
13. Namba M, Kurose M, Torigoe K, et al. Molecular cloning of the second major allergen, Cry j II, from Japanese cedar pollen. FEBS Lett 1994;353:124-8.
14. Sawatani M, Yasueda H, Akiyama K, et al. Immunological and physicochemical properties of Cry j 2, the second major allergen of Japanese cedar pollen (Cryptomeria japonica) [in Japanese with English summary]. Jpn J Allergol 1993;42:738-47.
15. Sone T, Komiyama N, Shimizu K, Kusakabe T, Morikubo K, Kino K. Cloning and sequencing of cDNA coding for Cry j I, a major allergen of Japanese cedar pollen. Biochem Biophys Res Commun 1994;199:619-25.
16. Taniguchi Y, Ono A, Sawatani M, et al. Cry j I, a major allergen of Japanese cedar pollen, has pectate lyase enzyme activity. Allergy 1995;50:90-3.
17. Kawashima T, Taniai M, Taniguchi Y, et al. Antigenic analyses of sugi basic protein by monoclonal antibodies. I. Distribution and characterization of B-cell-tropic epitopes of Cry j I molecules. Int Arch Allergy Immunol 1992;98:110-17.
18. Kawashima T, Taniai M, Usui M, Ando S, Kurimoto M, Matuhasi T. Antigenic analyses of sugi basic protein by monoclonal antibodies. II. Detection of immunoreactive fragments in enzyme-cleaved Cry j 1. Int Arch Allergy Immunol 1992;98:118-26.
19. Chretien I, Kimmenade KAV, Pearce M, Banchereau J, Abrams J. Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods 1989;117:67-81.
20. Hashimoto M, Nigi H, Sakaguchi M, et al. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin Exp Allergy 1995;25:848-52.
21. Sakaguchi M, Inouye S, Suzuki S. Fluorometric enzymelinked immunosorbent assay for the measurement of IgE antibody to Cryptomeria japonica pollen [in Japanese with English summary]. Jpn J Allergol 1986;35:233-7.
22. Sugimura K, Ohno T, Kusuyama T, Azuma I. High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro. Melanoma Res 1992;2:191-6.
23. Gubler U, Chua AO, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A 1991;88:4143-7.
24. O'Brien RM, Thomas WR. Immune reactivity to Der p I and Der p II in house dust mite sensitive patients attending paediatric and adult allergy clinics. Clin Exp Allergy 1994;24:737-42.
25. O'Brien RM, Thomas WR, Wootton AM. T-cell responses to the purified major allergens from the house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol 1992;89:1021-31.
26. Gagnon R, Akoum A, Hebert J. Loi p I-induced IL-4 and IFN-y production by peripheral blood mononuclear cells of atopic and nonatopic subjects during and out of the pollen season. J Allergy Clin Immunol 1993;91:950-6.
27. Higgins JA, Lamb JR, Lake RA, O'Hehir RE. Polyclonal and clonal analysis of human CD4+ T-lymphocyte responses to nut extracts. Immunology 1995;84:91-7.
28. Marshall JD, Wen Y, Abrams JS, Umetsu DT. In vitro synthesis of IL-4 by human CD4+ T-cells requires repeated antigenic stimulation. Cell Immunol 1993;152:18-34.
29. Parronchi P, Macchia D, Piccinni M-P, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 1991;88:4538-42.
30. Secrist H, Dekruyff RH, Umetsu DT. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995;181:1081-9.
31. Byron KA, O'Brien RM, Varigos GA, Wootton AM. Dermatophagoides pteronyssinus II-induced interleukin-4 and interferon-γ expression by freshly isolated lymphocytes of atopic subjects. Clin Exp Allergy 1994;24:878-83.
32. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to leishmania major. Science 1992;257:539-42.
33. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181:1569-74.
34. Gately MK, Warrier RR, Honasoge S, et al. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 1994;6:157-67.
35. Hsieh C-S, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th1 CD4+ cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.
36. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T-helper 1 cell development in experimental leishmaniasis. J Immunol 1995;154:5320-30.
37. Seder RA, Gazzinelli R, Sher A, Pawl W. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A 1993;90:10188-92.
38. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
39. Lester MR, Hofer MF, Gately M, Trumble A, Leung DYM. Down-regulating effects of IL-4 and IL-10 on the TFN-γ response in atopic dermatitis. J Immunol 1995; 154:6174-81.
40. Dekruyff RH, Fang Y, Wolf SF, Umetsu DT. IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T-cells through an effect on antigen-presenting cells. J Immunol 1995;154:2578-87.
41. Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T-cells. J Immunol 1995;154:5071-9.
42. Wynn TA, Jankovic D, Hieny S, et al. IL-12 exacerbates rather than suppresses T-helper 2-dependent pathology in the absence of endogenous TFN-γ. J Immunol 1995; 154:3999-4009.